Paul J Fletcher

4PUBLICATIONS
4CO-AUTHORS
Instrumental methods (excl. immunological and bioassay methods)Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 30, 2021
The serotonin 2C receptor agonist lorcaserin, alone and in combination with the opioid receptor antagonist naltrexone, attenuates binge-like ethanol drinking.

Rayane I Tabbara, Zhaoxia Li, Paul J Fletcher

|Aug 08, 2019
Disruption of SynGAP-dopamine D1 receptor complexes alters actin and microtubule dynamics and impairs GABAergic interneuron migration.

Ping Su, Terence K Y Lai, Frankie H F Lee

|Mar 26, 2018
Clozapine reduces nicotine self-administration, blunts reinstatement of nicotine-seeking but increases responding for food.

Andrew R Abela, Zhaoxia Li, Anh D Lê

|Mar 03, 2018
Preclinical evidence for combining the 5-HT2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependence.

Paul J Fletcher, Zhaoxia Li, Leo B Silenieks

Pageof 1

Frequent Collaborators

2 joint publications

Andrew R Abela

1 joint publications

Ping Su

1 joint publications

Fang Liu

1 joint publications

Rayane I Tabbara